COCCO, ELEONORA
 Distribuzione geografica
Continente #
EU - Europa 485.970
NA - Nord America 22.063
AS - Asia 8.435
SA - Sud America 1.493
AF - Africa 175
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 24
Totale 518.185
Nazione #
IT - Italia 479.550
US - Stati Uniti d'America 21.767
SG - Singapore 3.542
CN - Cina 3.315
BR - Brasile 1.256
SE - Svezia 1.251
UA - Ucraina 1.242
NL - Olanda 1.190
DE - Germania 847
GB - Regno Unito 589
VN - Vietnam 565
FI - Finlandia 530
FR - Francia 243
CA - Canada 187
KR - Corea 182
HK - Hong Kong 130
IN - India 122
AR - Argentina 90
MX - Messico 79
JP - Giappone 77
AT - Austria 76
RU - Federazione Russa 75
PL - Polonia 71
BD - Bangladesh 64
ZA - Sudafrica 60
ES - Italia 59
BE - Belgio 49
IR - Iran 49
TR - Turchia 49
IQ - Iraq 44
MA - Marocco 44
EC - Ecuador 42
ID - Indonesia 35
UZ - Uzbekistan 34
CZ - Repubblica Ceca 33
PK - Pakistan 26
CO - Colombia 25
EU - Europa 25
SA - Arabia Saudita 24
VE - Venezuela 24
LT - Lituania 22
IL - Israele 21
AU - Australia 19
AZ - Azerbaigian 19
IE - Irlanda 19
AE - Emirati Arabi Uniti 18
EG - Egitto 17
CL - Cile 16
RO - Romania 16
PH - Filippine 15
CH - Svizzera 14
KE - Kenya 12
UY - Uruguay 12
AL - Albania 11
NP - Nepal 11
DZ - Algeria 10
GR - Grecia 10
JO - Giordania 10
PT - Portogallo 10
PY - Paraguay 10
TN - Tunisia 10
KZ - Kazakistan 9
PE - Perù 9
DK - Danimarca 8
PS - Palestinian Territory 8
TW - Taiwan 8
HU - Ungheria 7
OM - Oman 7
TH - Thailandia 7
BO - Bolivia 6
CR - Costa Rica 6
EE - Estonia 6
HR - Croazia 6
KG - Kirghizistan 6
KW - Kuwait 6
LB - Libano 6
MD - Moldavia 6
MY - Malesia 6
RS - Serbia 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
NZ - Nuova Zelanda 5
LV - Lettonia 4
NG - Nigeria 4
PA - Panama 4
BB - Barbados 3
BH - Bahrain 3
GT - Guatemala 3
GY - Guiana 3
LK - Sri Lanka 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
JM - Giamaica 2
Totale 518.158
Città #
Cagliari 467.165
Uta 10.670
Fairfield 2.335
Ashburn 2.122
Woodbridge 1.767
Singapore 1.451
Dallas 1.205
Chandler 1.196
Houston 1.112
Amsterdam 1.083
Boardman 1.042
Wilmington 982
Seattle 939
Ann Arbor 829
Cambridge 777
Nyköping 710
Beijing 676
Jacksonville 587
Los Angeles 467
Dearborn 365
Chicago 330
New York 321
Helsinki 291
Munich 291
Nanjing 287
Santa Clara 270
Shanghai 260
Boston 258
Hefei 257
Buffalo 219
Seoul 173
The Dalles 169
Milan 168
Ho Chi Minh City 151
Salt Lake City 136
San Diego 136
Dong Ket 122
Rome 121
Hong Kong 120
São Paulo 112
Guangzhou 108
London 103
Hanoi 100
Shenyang 99
Nanchang 96
Norwalk 96
Redwood City 90
Toronto 90
Redondo Beach 83
Elk Grove Village 80
Atlanta 79
Jiaxing 79
Hebei 71
Sassari 71
Tampa 66
Tokyo 65
Washington 64
Phoenix 56
Changsha 55
Warsaw 55
Tianjin 52
Brooklyn 51
Nuremberg 51
Verona 48
Montreal 43
Jinan 41
Stockholm 41
Frankfurt am Main 40
Rio de Janeiro 40
Columbus 39
Sterling 39
Johannesburg 38
Vienna 38
Turku 37
Council Bluffs 36
Mountain View 36
Orem 35
Brussels 34
Düsseldorf 34
Denver 33
Hangzhou 33
Zhengzhou 32
Mexico City 30
Lancaster 29
Tashkent 29
Redhill 28
Wuhan 28
Ningbo 27
San Jose 27
Miami 26
Curitiba 25
San Francisco 25
Pune 24
Belo Horizonte 23
Da Nang 23
Detroit 23
Domusnovas 23
Kunming 23
Naples 23
Porto Alegre 23
Totale 504.608
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.134
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.914
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.185
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.900
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.537
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.461
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.442
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.356
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.277
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.182
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.180
Overexpression of the cytokine BAFF and autoimmunity risk 4.057
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.989
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.966
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.881
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.868
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.833
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.810
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.800
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.769
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.762
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.695
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.652
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.629
Walking improvements with nabiximols in patients with multiple sclerosis 3.623
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.589
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.558
Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals 3.555
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.548
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.541
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.471
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.381
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.375
Impact of the media on future hope in multiple sclerosis 3.353
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.273
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.265
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.259
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.254
Multiple Sclerosis and environmental factors. 3.253
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.217
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.181
Oral agents in multiple sclerosis 3.180
Influence of treatments in multiple sclerosis disability: a cohort study 3.148
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.136
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.092
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.072
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.057
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study 3.043
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.032
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.023
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.001
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 2.978
Refining the connection between gait and cognition: training the body to improve the brain 2.944
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.941
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.940
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.938
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.927
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.903
Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis 2.867
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.850
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.833
Hourly trends of physical activity in people with Multiple Sclerosis 2.816
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.779
Do gait patterns differ in men and women with multiple sclerosis? 2.765
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.695
Postural adaptation during a Nintendo Wii balance training 2.639
Perception of risk and shared decision making process in multiple sclerosis 2.618
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.617
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.611
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.584
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.583
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.570
The relationships between physical activity, self-efficacy, and quality of life in people with multiple sclerosis 2.555
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.536
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.529
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.509
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.458
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.408
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.379
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.308
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.305
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.295
The cohort of the multiple sclerosis center of Cagliari 2.284
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.263
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.260
Induction and escalation therapies in multiple sclerosis 2.253
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.243
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.232
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.215
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.195
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.172
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.163
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.079
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.060
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.057
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.023
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.016
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.011
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.008
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.005
Totale 311.978
Categoria #
all - tutte 651.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 651.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153.888 0 0 0 0 0 13.812 9.462 8.005 4.108 7.202 7.062 4.237
2021/202225.919 3.270 1.763 1.115 2.039 2.209 1.580 1.217 1.264 2.468 2.858 3.383 2.753
2022/202336.235 3.108 5.156 5.038 3.231 3.069 3.597 1.763 2.760 2.009 2.109 2.761 1.634
2023/202438.874 2.396 1.901 1.510 2.537 3.741 6.434 5.206 3.347 1.961 2.893 3.507 3.441
2024/202598.907 28.032 28.966 11.450 8.286 4.316 4.788 6.787 483 1.114 1.990 1.689 1.006
2025/202611.153 1.758 1.093 2.417 2.373 1.798 1.714 0 0 0 0 0 0
Totale 519.509